Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Colburn

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Oncogene|February 25, 1999
Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformationR G Watts, C Huang, M R Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1999
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformationJ L Cmarik, H Min, G Hegamyer, et al.
Oncogene|April 21, 2001
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivationH S Yang, A P Jansen, R Nair, et al.
IARC Scientific Publications|January 1, 1984
Role of specific membrane and genetic changes in the mechanism of tumour promotion. Studies with promoter-resistant variantsN H Colburn, L Srinivas, G A Hegamyer, et al.
Carcinogenesis|May 1, 1999
Vanadate-induced activation of activator protein-1: role of reactive oxygen speciesM Ding, J J Li, S S Leonard, et al.
British Journal of Cancer|October 7, 2010
Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention TrialG Bobe, G Murphy, P S Albert, et al.
Cancer Research|March 1, 1978
Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cellsN H Colburn, W F Bruegge, J R Bates, et al.
Carcinogenesis; a Comprehensive Survey|January 1, 1985
Genes and signal transduction in tumor promotion: conclusions from studies with promoter resistant variants of JB-6 mouse epidermal cellsT D Gindhart, Y Nakamura, L A Stevens, et al.
International Journal of Cancer|May 4, 1995
The von Hippel-Lindau (VHL) disease tumor-suppressor gene is not mutated in nasopharyngeal carcinomasY Sun, A Hildesheim, H Li, et al.
Molecular Carcinogenesis|May 1, 1995
c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformationR G Watts, E T Ben-Ari, L R Bernstein, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Oncogene|February 25, 1999
Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformationR G Watts, C Huang, M R Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1999
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformationJ L Cmarik, H Min, G Hegamyer, et al.
Oncogene|April 21, 2001
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivationH S Yang, A P Jansen, R Nair, et al.
IARC Scientific Publications|January 1, 1984
Role of specific membrane and genetic changes in the mechanism of tumour promotion. Studies with promoter-resistant variantsN H Colburn, L Srinivas, G A Hegamyer, et al.
Carcinogenesis|May 1, 1999
Vanadate-induced activation of activator protein-1: role of reactive oxygen speciesM Ding, J J Li, S S Leonard, et al.
British Journal of Cancer|October 7, 2010
Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention TrialG Bobe, G Murphy, P S Albert, et al.
Cancer Research|March 1, 1978
Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cellsN H Colburn, W F Bruegge, J R Bates, et al.
Carcinogenesis; a Comprehensive Survey|January 1, 1985
Genes and signal transduction in tumor promotion: conclusions from studies with promoter resistant variants of JB-6 mouse epidermal cellsT D Gindhart, Y Nakamura, L A Stevens, et al.
International Journal of Cancer|May 4, 1995
The von Hippel-Lindau (VHL) disease tumor-suppressor gene is not mutated in nasopharyngeal carcinomasY Sun, A Hildesheim, H Li, et al.
Molecular Carcinogenesis|May 1, 1995
c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformationR G Watts, E T Ben-Ari, L R Bernstein, et al.
Pageof 12